These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6816068)

  • 1. Defibrination with ancrod in glomerulonephritis: effects on clinical and histologic findings and on blood coagulation.
    Pollak VE; Glueck HI; Weiss MA; Lebron-Berges A; Miller MA
    Am J Nephrol; 1982; 2(4):195-207. PubMed ID: 6816068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinolysis in glomerulonephritis treated with ancrod: renal functional, immunologic and histopathologic effects.
    Kim S; Wadhwa NK; Kant KS; Pollak VE; Glas-Greenwalt P; Weiss MA; Hong CG
    Q J Med; 1988 Nov; 69(259):879-905. PubMed ID: 3078212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lupus nephritis with thrombosis and abnormal fibrinolysis: effect of ancrod.
    Kant KS; Pollak VE; Dosekun A; Glas-Greenwalt P; Weiss MA; Glueck HI
    J Lab Clin Med; 1985 Jan; 105(1):77-88. PubMed ID: 3968467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of fibrinolytic and defibrinating agents in established experimental glomerulonephritis.
    Tipping PG; Thomson NM; Holdsworth SR
    Br J Exp Pathol; 1986 Aug; 67(4):481-91. PubMed ID: 3741774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ancrod improves survival in murine systemic lupus erythematosus.
    Cole EH; Glynn MF; Laskin CA; Sweet J; Mason N; Levy GA
    Kidney Int; 1990 Jan; 37(1):29-35. PubMed ID: 2299806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficiency of a plasma factor stimulating vascular prostacyclin generation in patients with lupus nephritis and glomerular thrombi and its correction by ancrod: in-vivo and in-vitro observations.
    Kant KS; Dosekun AK; Chandran KG; Glas-Greenwalt P; Weiss MA; Pollak VE
    Thromb Res; 1982 Sep; 27(6):651-8. PubMed ID: 6758185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ancrod: normalization of fibrinolytic enzyme abnormalities in patients with systemic lupus erythematosus and lupus nephritis.
    Glas-Greenwalt P; Kant KS; Dosekun A; Frazier J; Allen C; Pollak VE
    J Lab Clin Med; 1985 Jan; 105(1):99-107. PubMed ID: 3871465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ancrod and rtPA on fibrin accumulation, glomerular inflammation and renal function in nephrotoxic nephritis.
    Mathieson PW; Thiru S; Peters DK; Oliveira DB
    Int J Exp Pathol; 1991 Dec; 72(6):679-93. PubMed ID: 1768613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrin independent proinflammatory effects of tissue factor in experimental crescentic glomerulonephritis.
    Cunningham MA; Kitching AR; Tipping PG; Holdsworth SR
    Kidney Int; 2004 Aug; 66(2):647-54. PubMed ID: 15253718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defibrination with ancrod in nephrotoxic nephritis in rabbits.
    Thomson NM; Moran J; Simpson IJ; Peters DK
    Kidney Int; 1976 Nov; 10(5):343-7. PubMed ID: 794557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet aggregation following defibrination with ancrod.
    Slade CL; Andes WA; Mason AD
    Thromb Haemost; 1976 Nov; 36(2):424-9. PubMed ID: 1036842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble fibrin complex production and proteolysis during ancrod therapy.
    McKillop C; Edgar W; Prentice CR; Forbes CD
    Scott Med J; 1975 May; 20(3):139-40. PubMed ID: 127379
    [No Abstract]   [Full Text] [Related]  

  • 13. Factor VIII/von Willebrand factor in glomerular nephropathies.
    Coppola R; Guerra L; Ruggeri ZM; Tarantino A; Mannucci PM; Ponticelli C
    Clin Nephrol; 1981 Nov; 16(5):217-22. PubMed ID: 6796318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The participation of macrophages, glomerular procoagulant activity, and factor VIII in glomerular fibrin deposition. Studies on anti-GBM antibody-induced glomerulonephritis in rabbits.
    Tipping PG; Holdsworth SR
    Am J Pathol; 1986 Jul; 124(1):10-7. PubMed ID: 3089018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment by defibrination with ancrod in a patient with hyperacute renal allograft failure and a deficiency of plasma prostacyclin stimulating factor.
    Dosekun AK; First MR; Chandran PK; Kant KS; Glas-Greenwalt P; Weiss MA; Alexander JW; Pollak VE
    Clin Nephrol; 1982 Aug; 18(2):101-5. PubMed ID: 6754189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ancrod in systemic lupus erythematosus with thrombosis. Clinical and fibrinolysis effects.
    Dosekun AK; Pollak VE; Glas-Greenwalt P; Kant KS; Penovich P; Lebron-Berges A; Weiss MA; Levinson JE
    Arch Intern Med; 1984 Jan; 144(1):37-42. PubMed ID: 6229228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A quantitative evaluation of anticoagulants in experimental nephrotoxic nephritis.
    Thomson NM; Simpson IJ; Peters DK
    Clin Exp Immunol; 1975 Feb; 19(2):301-8. PubMed ID: 1212801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of defibrination on macrophage participation in rabbit nephrotoxic nephritis: studies using glomerular culture and electronmicroscopy.
    Holdsworth SR; Thomson NM; Glasgow EF; Atkins RC
    Clin Exp Immunol; 1979 Jul; 37(1):38-43. PubMed ID: 487657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential studies of glomerular crescent formation in rats with antiglomerular basement membrane-induced glomerulonephritis and the role of coagulation factors.
    Silva FG; Hoyer JR; Pirani CL
    Lab Invest; 1984 Oct; 51(4):404-15. PubMed ID: 6434880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of heparin, urokinase, and ancrod on intraglomerular coagulation induced in progressive Masugi nephritis.
    Dohi K; Fujioka M; Nakamoto Y
    Acta Pathol Jpn; 1982 Nov; 32(6):1047-52. PubMed ID: 6760667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.